Skip to main content

Table 2 Analysis of the cure rates at day 63 by site and overall (ITT and PP populations)

From: Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India

 

PCR-corrected

Uncorrected

DP

A+M

DP

A+M

N (%)

N (%)

N (%)

N (%)

95% CI

95% CI

95% CI

95% CI

ITT Population

Heterogeneity test

p=0.398a

p=0.800a

Guwahati

44 (95.7)

22 (100)

44 (95.7)

22 (100)

(DP=46, A+M=22)

89.76; 100

n.a.

89.76; 100

n.a.

Goa

19 (100)

8 (88.9)

19 (100)

7 (77.8)

(DP=19, A+M=9)

n.a.

68.4; 100

n.a.

50.6; 100

Mangalore

18 (50.0)

11 (61.1)

12 (33.3)

5 (27.8)

(DP=36, A+M=18)

33.7; 66.3

38.6; 83.6

17.9; 48.7

7.1; 48.5

Total

81 (80.2)

41 (83.7)

75 (74.3)

34 (69.4)

(DP=101, A+M=49)

72.4; 88.0

73.3; 94.0

65.7; 82.8

56.5; 82.3

95% CI for DP - A+M

−16.4; 9.5

−10.6; 20.3

PP population

Heterogeneity test

p=0.978b

p=0.574a

Guwahati

42 (100)

22 (100)

42 (100)

22 (100)

(DP=42, A+M=22)

n.a.

n.a.

n.a.

n.a.

Goa

19 (100)

8 (100)

19 (100)

7 (87.5)

(DP=19, A+M=8)

n.a.

n.a.

n.a.

64.6; 100

Mangalore

18 (94.7)

11 (100)

12 (63.2)

5 (45.5)

(DP=19, A+M=11)

84.7; 100

n.a.

41.5; 84.9

16.0; 74.9

Total

79 (98.8)

41 (100)

73 (91.3)

34 (82.9)

(DP=80, A+M=41)

96.3; 100

n.a.

85.1; 97.4

71.4; 94.4

95% CI for DP - A+M

−3.7; 1.2

−4.8; 21.4

  1. DP, dihydroartemisinin-piperaquine; A+M, artesunate-mefloquine; n.a., not assessable.
  2. aBreslow-Day; bLogistic Regression.